Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 136, Issue 9, Pages 2055-2064
Publisher
Wiley
Online
2014-10-12
DOI
10.1002/ijc.29269
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle
- (2014) François Lamoureux et al. Nature Communications
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival
- (2013) D H Lee et al. Oncogenesis
- BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
- (2012) C. J. Ott et al. BLOOD
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
- (2012) Federico Andreoli et al. CURRENT PHARMACEUTICAL DESIGN
- The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines
- (2012) Claudia M.J. Lucero et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
- (2011) Dhong Hyun Lee et al. CANCER LETTERS
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- A c-Myc–SIRT1 feedback loop regulates cell growth and transformation
- (2009) Jian Yuan et al. JOURNAL OF CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started